35
Views
0
CrossRef citations to date
0
Altmetric
Editorial Foreword

Treatment of generalized anxiety disorder

Pages 183-184 | Published online: 25 Nov 2022

References

  • [APA] American Psychiatric Association2000Diagnostic and Statistical Manual of Mental Disorders4th Ed Text Revision (DSM-IV-TR)WashingtonAPA4726
  • AouizerateBGuehlDCunyE2005Updated overview of the putative role of the serotoninergic system in obsessive-compulsive disorderNeuropsychiatr Dis Treat12314318568072
  • BaldwinDSAjelK2007Role of pregabalin in the treatment of generalized anxiety disorderNeuropsychiatr Dis Treat3185191
  • BaldwinDSAndersonIMNuttDJ2005Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for PsychopharmacologyJ Psychopharmacol195679616272179
  • BaldwinDSPolkinghornC2005Evidence-based pharmacotherapy of generalized anxiety disorderInt J Neuropsychopharmacol829330215576000
  • [CADTGI] Canadian Anxiety Disorders Treatment Guidelines Intiative2007Canad J Psychiatry
  • GreenbergPSisitskyTKesslerR1999The economic burden of anxiety disorders in the 1990sJ Clin Psychiatry604273510453795
  • IronsJ2005Fluvoxamine in the treatment of anxiety disordersNeuropsychiatr Dis Treat12899918568110
  • KatzmanMAJacobsL2007Venlafaxine in the treatment of panic disorderNeuropsychiatr Dis Treat35967
  • KesslerRMcGonagleKZhaoS1994Lifetime and 12-month prevalence of DSM-IIIR psychiatric disorders in the United States. Results from the national comorbidity surveyArch Gen Psychiatry518198279933
  • LewinABStorchEAGeffkenER2006A neuropsychiatric review of pediatric obsessive-compulsive disorder: etiology and efficacious treatmentsNeuropsychiatr Dis Treat22131
  • LiebRBeckerEAltamuraC2005The epidemiology of generalized anxiety disorder in EuropeEur Neuropsychopharmacol154455215951160
  • StrawnJRGeraciotiTD2007Pregabalin treatment of generalized anxiety disorderNeuropsychiatr Dis Treat3237243

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.